ArticleVaccines2025
Measles Vaccination Coverage and Anti-Measles Herd Immunity Levels in the World and WHO Regions Worsened from 2019 to 2023.
Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Global and regional burden of measles and vaccine coverage among children under 5 years, 1990-2023: a Global Burden of Disease Study.Nature medicine · 2026Article
- Article
- Measles and Rubella Elimination Trends in the WHO Eastern Mediterranean Region, 2023-2024: Progress and Recent Epidemiological Shifts.Vaccines · 2026Article
- Measles challenges: global resurgence and factors affecting eradication.Italian journal of pediatrics · 2026Review
- Resurgence of measles in Bangladesh amid a global upsurge: an urgent call for emergency public health response.Tropical medicine and health · 2026Article
- Article
- Viral threats to pregnancy: Global health risks in the era of pandemics.Advances in virus research · 2026Review
- A cross-sectional study of seroprevalence in Armenia, 2025: measles, mumps, rubella, and diphtheria.Frontiers in public health · 2026Article
- Vaccines and Vaccination: Feature Papers.Vaccines · 2025Article
- Surge in Measles Cases in Italy from August 2023 to January 2025: Characteristics of Cases and Public Health Relevance.Vaccines · 2025Article
- A Comparison of Vaccination Policies and Immunity Assessment for Measles Control: Insights from the United States and Japan.Viruses · 2025Review
- Comparative Immunogenicity and Safety of Measles-Mumps-Rubella Vaccine When Administered Using Needle Free Injection System to That with Conventional Needle-Syringe in India: A Randomized, Parallel Group Study.Medical devices (Auckland, N.Z.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe objectives of this study were as follows: to determine mean percentages of measles vaccination coverage with zero, one and two doses of vaccine and anti-measles herd immunity levels in World Health Organization (WHO) regions in 2023; to assess variations in measles vaccination coverage and anti-measles herd immunity-related indicators from 2019 to 2023; and to assess whether zero-dose measles vaccination coverage indicators were on track to achieve the Immunization Agenda 2030 objective.
methodsMean percentages of vaccination coverage with two, one and zero doses of measles vaccine in WHO regions in 2023 were calculated using data from the WHO/UNICEF global and regional immunization information system.
resultsIn 2023, the global mean two-dose measles vaccination coverage was 65.3%, and mean two-dose vaccination coverage was lower than 95% in all WHO regions; the mean prevalence of measles-protected individuals in the target vaccination population was 87.6%, and anti-measles herd immunity levels in the target vaccination population were sufficient to block the transmission of measles viruses with greater transmissibility (R
conclusionThis study found that all measles-vaccination-coverage-related indicators worsened from 2019 to 2023, and the zero-dose measles vaccination coverage and number of zero-dose measles children in 2023 were not on track to achieve the AI2030 objective. Interventions to increase routine two-dose measles vaccination coverage should be developed in all WHO regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.